Loading...
Regencell Bioscience Holdings Ltd's top 1 named executive officers received combined total compensation of $12.6 million in fiscal year 2023.
The named executive officers disclosed in Regencell Bioscience Holdings Ltd's 2023 proxy statement are:New York () with total compensation of $12.6 million.
100% equity
Based on 20-F filed 2024-10-25 · FY2023
FY2023 total compensation breakdown
$12.6M total compensation
New York earned $12.6M in FY2023 — here's how that breaks down.
$12.6M
100% of total
We need at least two years of pay and stock data to show the trend.
Pay changes vs. stock performance
1 year of data
Recent insider trades by officers and directors
For analysts and deep research
Historical compensation data from latest proxy filing
| Year | Executive | Salary | Bonus & Incentive | Stock Awards | Option Awards | Other Adj. | Total |
|---|---|---|---|---|---|---|---|
| 2023 | New York | $0.00M | $0.00M | $12.6M | $0.00M | $0.00M | $12.6M |
Salary = base cash pay. Bonus & Incentive combines annual bonus and non-equity plans. Equity amounts are grant-date fair values. Other Adj. captures pension changes, perquisites, and any reconciliation items so the total matches the reported figure.
Get one email when new executive compensation data is filed and processed.